METABOLISM OF GLIOFIBRILLARY ACIDIC PROTEIN IN PREGNANT WOMEN WITH POST-CONCUSSION SYNDROME
https://doi.org/10.17749/2313-7347.2017.11.4.043-047
Abstract
The aim: to evaluate the astroglial neurospecific protein – gliofibrillary acidic protein (GFAP) in the blood serum of pregnant women with post-concussion syndrome (PCS) resulted from a mild closed brain injury. The serum level of GFAP was earlier proposed to be used as a marker of the state of the blood-brain barrier (BBB) and a predictor of obstetric and perinatal complications.
Materials and methods. To evaluate the permeability of the BBB and the integrity of astrocytes during pregnancy, we measured GFAP (using the enzyme immunoassay) in the sera of 93 women: 41 with PCS (main group), 31 somatically healthy pregnant women (comparison group), and 21 non-pregnant women of the reproductive age (control group).
Results. In healthy pregnant women, the level of GFAP did not significantly differ from that in the non-pregnant women and did not exceed a threshold value of 4.0 ng/ml. In most of the pregnant women with PCS (70.73%), the GFAP values exceeded the threshold level starting from the first trimester and tended to increase subsequently, which was indicative of immunological sensitization.
Conclusion. In the obstetric and neurological practice, pregnant women with PCS are recommend to be tested for their serum GFAP as a marker of immunological sensitization and a predictor of pregnancy and delivery complications as well as neurological deterioration.
About the Authors
V. V. Simrok
Lugansk State Medical University named after Saint Luke, Health Ministry of Lugansk People's Republic.
Russian Federation
Russian Federation
Simrok Vasiliy Vasilievich – MD, Professor, Head of Department of Obstetrics and Gynecology.
ul. 50-letiya Oborony Luganska, 1, Lugansk, 91045.
I. V. Tsyganenko
Lugansk State Medical University named after Saint Luke, Health Ministry of Lugansk People's Republic.
Russian Federation
Russian Federation
Tsyganenko Irina Vasilievna – Assistant, Department of Obstetrics and Gynecology,
ul. 50-letiya Oborony Luganska, 1, Lugansk, 91045.
References
1. Smychek V.B., Ponomareva E.N. Craniocerebral trauma (clinic, treatment, examination, rehabilitation): monograph [Cherepno-mozgovaya travma (klinika, lechenie, ekspertiza, reabilitaciya): monografiya]. Minsk: NII medicinskoj ekspertizy i reabilitacii. 2010: 430 s (in Russian).
2. Apresyan S.V. Pregnancy and childbirth in extragenital diseases [Beremennost' i rody pri ekstragenital'nyh zabolevaniyah (Pod red. V.E. Radzinskogo)]. Moskva: GEOTAR-Media. 2009: 457 s (in Russian).
3. Vedunova M.V., Terentyeva K.A., Shelchkova N.A. et al. The diagnostic value of the determination of the concentration of neurotrophic factors and neuron-specific enolase in blood of newborns with CNS disorders [Diagnosticheskoe znachenie opredeleniya koncentracii nejrotroficheskih faktorov i nejronspecificheskoj enolazy v krovi novorozhdennyh s narusheniyami CNS]. Sovremennye tekhnologii v medicine. 2015; 7 (2): 25-32 (in Russian).
4. Colantonio A. Women's health outcomes after traumatic brain injury. J Womens Health. 2010; 19 (6): 11-6.
5. Blinov D.V. Modern understanding of the role of the resistance disorder of hematoencephalic barrier in the pathogenesis of CNS diseases. Part 1: Structure and formation of hematoencephalic barrier [Covremennye predstavleniya o roli narusheniya rezistentnosti gematoencefalicheskogo bar'era v patogeneze zabolevanij CNS. Chast' 1: Stroenie i formirovanie gematoencefalicheskogo bar'era]. Epilepsiya i paroksizmal'nye sostoyaniya. 2013; 5 (3): 65-75 (in Russian).
6. Blinov D.V. Current understanding of the role of the resistance of hematoencephalic barrier in the pathogenesis of CNS diseases. Part 2: Functions and mechanisms of damage of hematoencephalic barrier [Covremennye predstavleniya o roli narusheniya rezistentnosti gematoencefalicheskogo bar'era v patogeneze zabolevanij CNS. Chast' 2: Funkcii i mekhanizmy povrezhdeniya gematoencefalicheskogo bar'era]. Epilepsiya i paroksizmal'nye sostoyaniya. 2014; 6 (1): 70-84 (in Russian).
7. Michael V. Astrocytes: biology and pathology. Acta Neuropathol. 2010; 44: 163-5.
8. Blinov D.V. Patients with neurological disorders: the rationale for pharmacoeconomic evaluation of optimization of the costs of management using neurospecific proteins as markers to increase the hematoencephalic barrier permeability [Pacienty s nevrologicheskimi rasstrojstvami: obosnovanie neobhodimosti farmakoekonomicheskoj ocenki optimizacii zatrat na vedenie s ispol'zovaniem nejrospecificheskih belkov v kachestve markerov povysheniya pronicaemosti gematoencefalicheskogo bar'era]. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2014; 7 (1): 40-5 (in Russian).
9. Blinov D.V. Diagnostic value of EEG and biochemical markers of brain damage in hypoxic-ischemic encephalopathy [Diagnosticheskoe znachenie EEG i biohimicheskih markerov povrezhdeniya mozga pri gipoksicheskiishemicheskoj encefalopatii]. Epilepsiya i paroksizmal'nye sostoyaniya. 2016; 8 (4): 91-8 (in Russian). DOI: 10.17749/2077-8333.2016.8.4.091-098.
10. Blinov D.V. A modern view of objective diagnosis of the violation of resistance of HEB in the rehabilitation of children with perinatal hypoxic-ischemic lesions of the central nervous system [Covremennyj vzglyad na ob"ektivnuyu diagnostiku narusheniya rezistentnosti GEB v reabilitacii detej s perinatal'nymi gipoksicheskiishemicheskimi porazheniyami CNS]. Detskaya i podrostkovaya reabilitaciya. 2016; 2 (27): 32-9 (in Russian).
Review
For citations:
Simrok V.V., Tsyganenko I.V. METABOLISM OF GLIOFIBRILLARY ACIDIC PROTEIN IN PREGNANT WOMEN WITH POST-CONCUSSION SYNDROME. Obstetrics, Gynecology and Reproduction. 2017;11(4):43-47. (In Russ.) https://doi.org/10.17749/2313-7347.2017.11.4.043-047
Views: 601
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
